TransValid-A, NCT03034473: Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC-II-IV, With a 5-Fluorouracil-based Standard Radiochemotherapy Followed by Total Mesorectal Excision. |
|
|
| Active, not recruiting | N/A | 200 | Europe | Translational Research and multimodal treatment | University Medical Center Goettingen, German Research Foundation | Locally Advanced Rectal Cancer | 08/24 | 08/24 | | |
